PharmaBoardroom

Interview: John Sampalis, CEO, JSS Medical Research, Canada

Industry veteran and CEO of JSS Medical research explains what he thinks is going wrong with clinical research in Canada today, how Canadian CROs are…

Interview: Alain Leclerc, Co-Managing Partner, Goudreau Gage…

The co-managing partner of one of Canada's leading IP law firms discusses the landscape for intellectual property in the pharmaceutical industry in…

Interview: Gino Martel, Partner, BCF Business Law, Canada

Gino Martel explains the present environment for M&As, divestitures and out-licensing in the Canadian biotech sector, the different ways that…

Interview: Éric Gervais, Executive Vice President, Médunik…

As the only country in the G8 without an orphan drugs act, the president of Médunik, a company focused on bringing orphan drugs into the country,…

Biotech as business: the Bavarian Nordic story

If there is one thing that successful Danish companies have in common with one another, it is the clear recognition of abundant opportunities outside…

Interview: Calvin Tsai CEO of Orient Pharma & Jack Wu,…

Calvin Tsai and Jack Wu talk about their two-pronged international approach through pharmaceuticals and nutricare. The head of the nutricare business…

Interview: Sybil Dahan, President, Triton Pharma, Canada

An interesting perspective on the Canadian market, and its opportunities and challenges in drug registration on a regional level from the President of…

Interview: Christian Dyvig, CEO, Lundbeck Foundation

The CEO of one of Denmark’s largest foundations talks about the merits of the foundation model, and the current strategies of both Lundbeck and ALK…

Interview: Roberto Bellini, President & CEO, Bellus Health,…

The CEO of Bellus Health outlines his strategy since 2010 to change the focus of the company from Alzheimer’s to a niche disease, AA amyloidosis, as…

Interview: Raphael Hofstein, President & CEO, MaRS…

The CEO of MaRS Innovation, a commercialization incubator created by 16 of Toronto's best research institutions and supported by the government,…

Nicolas Marceau – Minister of Finance & Economy,…

Minister Marceau addresses the changes in policy in Quebec relating to the pharmaceutical and life sciences sectors, and the incentives in place to…

Colombia’s Law 100: from 93 to infinity?

President Santos appointed economist Alejandro Gaviria as the new Minister of Health and Social Protection in September 2012. Gaviria‰Ûªs priority…

Tagged with